Northern Trust’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $23.4M | Buy |
505,044
+66,881
| +15% | +$2.41M | ﹤0.01% | 1708 |
|
|
2026
Q1 | $10.7M | Buy |
438,163
+35,700
| +9% | +$845K | ﹤0.01% | 2030 |
|
|
2025
Q4 | $9.99M | Sell |
402,463
-20,786
| -5% | -$552K | ﹤0.01% | 2089 |
|
|
2025
Q3 | $12M | Sell |
423,249
-11,219
| -3% | -$304K | ﹤0.01% | 2011 |
|
|
2025
Q2 | $10.8M | Sell |
434,468
-26,334
| -6% | -$742K | ﹤0.01% | 2029 |
|
|
2025
Q1 | $14.3M | Sell |
460,802
-6,377
| -1% | -$212K | ﹤0.01% | 1834 |
|
|
2024
Q4 | $14.7M | Buy |
467,179
+43,032
| +10% | +$2.04M | ﹤0.01% | 1894 |
|
|
2024
Q3 | $24.6M | Sell |
424,147
-2,239
| -0.5% | -$110K | ﹤0.01% | 1492 |
|
|
2024
Q2 | $17.3M | Sell |
426,386
-21,008
| -5% | -$833K | ﹤0.01% | 1647 |
|
|
2024
Q1 | $18.8M | Sell |
447,394
-5,338
| -1% | -$208K | ﹤0.01% | 1635 |
|
|
2023
Q4 | $17.3M | Sell |
452,732
-14,774
| -3% | -$492K | ﹤0.01% | 1715 |
|
|
2023
Q3 | $14.4M | Buy |
467,506
+4,285
| +0.9% | +$148K | ﹤0.01% | 1760 |
|
|
2023
Q2 | $14.6M | Buy |
463,221
+30,699
| +7% | +$1.05M | ﹤0.01% | 1792 |
|
|
2023
Q1 | $15.8M | Buy |
432,522
+9,628
| +2% | +$337K | ﹤0.01% | 1710 |
|
|
2022
Q4 | $12.5M | Buy |
422,894
+12,104
| +3% | +$389K | ﹤0.01% | 1852 |
|
|
2022
Q3 | $16M | Buy |
410,790
+2,974
| +0.7% | +$136K | ﹤0.01% | 1648 |
|
|
2022
Q2 | $15.7M | Buy |
407,816
+2,565
| +0.6% | +$97.6K | ﹤0.01% | 1705 |
|
|
2022
Q1 | $19.6M | Sell |
405,251
-16,675
| -4% | -$860K | ﹤0.01% | 1690 |
|
|
2021
Q4 | $31M | Sell |
421,926
-3,741
| -0.9% | -$307K | 0.01% | 1463 |
|
|
2021
Q3 | $38.8M | Buy |
425,667
+54,979
| +15% | +$4.68M | 0.01% | 1283 |
|
|
2021
Q2 | $23.3M | Buy |
370,688
+125,891
| +51% | +$4.65M | ﹤0.01% | 1784 |
|
|
2021
Q1 | $6.63M | Sell |
244,797
-20,051
| -8% | -$482K | ﹤0.01% | 2563 |
|
|
2020
Q4 | $4.84M | Sell |
264,848
-6,653
| -2% | -$120K | ﹤0.01% | 2705 |
|
|
2020
Q3 | $4.87M | Buy |
271,501
+68,159
| +34% | +$1.18M | ﹤0.01% | 2544 |
|
|
2020
Q2 | $3.35M | Buy |
203,342
+53
| +0% | +$834 | ﹤0.01% | 2763 |
|
|
2020
Q1 | $2.63M | Buy |
203,289
+47,260
| +30% | +$771K | ﹤0.01% | 2692 |
|
|
2019
Q4 | $2.87M | Sell |
156,029
-183,375
| -54% | -$3.04M | ﹤0.01% | 2908 |
|
|
2019
Q3 | $5.98M | Buy |
339,404
+223,273
| +192% | +$3.82M | ﹤0.01% | 2451 |
|
|
2019
Q2 | $1.94M | Sell |
116,131
-2,333
| -2% | -$42.4K | ﹤0.01% | 3095 |
|
|
2019
Q1 | $2.17M | Buy |
118,464
+6,581
| +6% | +$126K | ﹤0.01% | 3033 |
|
|
2018
Q4 | $2.22M | Buy |
111,883
+27,894
| +33% | +$522K | ﹤0.01% | 2988 |
|
|
2018
Q3 | $1.85M | Sell |
83,989
-153,306
| -65% | -$3.23M | ﹤0.01% | 3256 |
|
|
2018
Q2 | $6.14M | Buy |
+237,295
| New | +$4.07M | ﹤0.01% | 2576 |
|
Other funds holding ASTH
3C
Northern Trust's ASTH Position: Q2 2026 in Review
Northern Trust increased its Astrana Health (ASTH) stake by 15% in Q2 2026, buying an estimated $2.41M and bringing the position to 505,044 shares worth $23.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1708.
Northern Trust first reported a position in ASTH in Q2 2018 and has held it in 33 quarters since. The position peaked at $38.8M in Q3 2021. 209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.
- Northern Trust held 505,044 shares of Astrana Health worth $23.4M as of Q2 2026.
- Northern Trust bought 66,881 Astrana Health shares in Q2 2026, an estimated $2.41M.
- Astrana Health made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #1708 holding.
- Northern Trust first reported a position in Astrana Health in Q2 2018 and has held it in 33 quarters since.
- Northern Trust's Astrana Health position peaked at $38.8M in Q3 2021.
- 209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.
Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.